Kelly Leanne bought GRI

August 26, 2025 · Form 4 insider transaction

Kelly Leanne bought 11,854 shares of GRI Bio, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
11,854
Price
$0.00
Total value
N/A
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 26, 2025
Filing dateAugust 27, 2025
Shares owned after11,854
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Options to purchase 7,424 shares vested in full upon the date of grant and options to purchase 4,430 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant.

View the original Form 4 on SEC EDGAR